Bausch + Lomb Indocollyre eye drops

Indocollyre is a specialized ophthalmic solution containing indomethacin, used primarily to inhibit miosis during cataract surgery and for post-operative inflammation. The brand is part of the extensive portfolio of Bausch + Lomb, a pioneer in eye health founded in Rochester, New York, in 1853.

Manufacturing for Bausch + Lomb products is distributed globally, with major facilities in the United States, Europe (such as France and Germany), and Asia. In 2013, Bausch + Lomb was acquired by Valeant Pharmaceuticals (now Bausch Health Companies Inc.), but it was subsequently spun off again. As of recent corporate restructuring, Bausch + Lomb Corporation operates as a distinct publicly traded entity specializing in vision care, surgical equipment, and ophthalmic pharmaceuticals, maintaining its global headquarters in Canada and the US.